profile image
ABBVIE is deep red today at -7.6%. Who knows why?
profile image
@Wundersamen Patent from blockbuster humira has expired. Quarterly figures were published today. Profit decline was as expected by analysts, but investors are used to the company exceeding expectations. So sharp price drop, in my opinion, not justified. 🤷🏼‍♂️